Interestingly, while psychiatric side-effects are well known with anti-TNF-α drug treatments (Thillard et al., 2020), these same drugs can improve depressive symptoms but only in patients suffering from depression with high levels of peripheral inflammatory markers (Raison et al., 2013). This evidence concerns the gene TNF and major depressive disorder.